Literature DB >> 306989

Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.

R V Goering, C C Sanders, W Sanders.   

Abstract

The activity of BL-S786 was compared to that of cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice. In broth dilution tests, the activity of BL-S786 was less than cephalothin or cefamandole against Staphylococcus aureus and less than cefamandole or cefoxitin against Haemophilus influenzae. BL-S786 and cefamandole were the two most active drugs against cephalothin-sensitive Enterobacteriaceae. In tests with cephalothin-resistant Enterobacteriaceae, BL-S786 was generally less active than cefamandole but more active than cefoxitin against all strains except Proteus and Providencia. Regardless of the comparative in vitro activity of the four drugs, BL-S786 was the most effective drug in treatment of mice lethally infected with Enterobacteriaceae. Protection from lethality was associated with clearance of bacteremia by each of the four drugs. In several tests where in vitro activity was not predictive of in vivo efficacy, selection of resistance in vivo was found to have occurred.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306989     DOI: 10.7164/antibiotics.31.363

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

1.  beta-Lactamases and resistance to cephalosporins.

Authors:  R P Mouton
Journal:  Antonie Van Leeuwenhoek       Date:  1981-03       Impact factor: 2.271

Review 2.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

3.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

4.  Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

Authors:  T D Gootz; D B Jackson; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

6.  Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.

Authors:  R V Goering; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 7.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

Review 8.  Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.

Authors:  R P Mouton
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

9.  Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Authors:  D G Beckwith; J A Jahre
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

10.  Treatment of cellulitis with ceforanide.

Authors:  D M Musher; V Fainstein; E J Young
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.